10 Biggest Price Target Changes For Tuesday
Morgan Stanley raised the price target on Microsoft Corporation (NASDAQ: MSFT) from $305 to $331. Microsoft shares rose 0.1% to $297.03 in pre-market trading.
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 13)
HC Wainwright & Co. Downgrades Itamar Medical to Neutral, Lowers Price Target to $31
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Itamar Medical (NASDAQ:ITMR) from Buy to Neutral and lowers the price target from $36 to $31.
Cowen & Co. Downgrades Itamar Medical to Market Perform, Raises Price Target to $31
Cowen & Co. analyst Joshua Jennings downgrades Itamar Medical (NASDAQ:ITMR) from Outperform to Market Perform and raises the price target from $30 to $31.
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53.
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75.
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva’s COVID-19 Vaccine Contract
Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84.
